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Abstract
Differentiation of oligodendrocyte progenitor cells (OPCs) into mature oligodendrocytes requires extensive changes in gene
expression, which are partly mediated by post-translational modifications of nucleosomal histones. An essential
modification for oligodendrocyte differentiation is the removal of acetyl groups from lysine residues which is catalyzed
by histone deacetylases (HDACs). The transcriptional targets of HDAC activity within OPCs however, have remained elusive
and have been identified in this study by interrogating the oligodendrocyte transcriptome. Using a novel algorithm that
allows clustering of gene transcripts according to expression kinetics and expression levels, we defined major waves of co-
regulated genes. The initial overall decrease in gene expression was followed by the up-regulation of genes involved in lipid
metabolism and myelination. Functional annotation of the down-regulated gene clusters identified transcripts involved in
cell cycle regulation, transcription, and RNA processing. To define whether these genes were the targets of HDAC activity,
we cultured rat OPCs in the presence of trichostatin A (TSA), an HDAC inhibitor previously shown to inhibit oligodendrocyte
differentiation. By overlaying the defined oligodendrocyte transcriptome with the list of ‘TSA sensitive’ genes, we
determined that a high percentage of ‘TSA sensitive’ genes are part of a normal program of oligodendrocyte differentiation.
TSA treatment increased the expression of genes whose down-regulation occurs very early after induction of OPC
differentiation, but did not affect the expression of genes with a slower kinetic. Among the increased ‘TSA sensitive’ genes
we detected several transcription factors including Id2, Egr1, and Sox11, whose down-regulation is critical for OPC
differentiation. Thus, HDAC target genes include clusters of co-regulated genes involved in transcriptional repression. These
results support a de-repression model of oligodendrocyte lineage progression that relies on the concurrent down-
regulation of several inhibitors of differentiation.
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Introduction
Differentiated oligodendrocytes (OLs) wrap a lipid-rich mem-
brane, termed myelin, around axons providing insulation of
electrical signals as well as trophic support [1–3]. As myelin
formation requires the synthesis of both lipids and myelin specific
proteins, such as MBP and PLP [4], a complex cellular machinery
is required to properly synthesize and localize these components
[5–8]. Therefore in addition to producing myelin proteins, the
mature OL must synthesize enzymes affecting lipid metabolism
and proteins involved in RNA and vesicular transport.
The differentiation of oligodendrocyte precursor cells (OPCs)
into myelinating OLs requires a substantial change in the proteins
which are synthesized [7,9,10]. This switch involves cascades of
transcriptional and post-translational events mediated by DNA-
binding proteins, micro-RNAs and chromatin regulators [11–15].
In particular, the known transcriptional mechanisms during the
initial steps of OPC differentiation suggest a general de-repression
model of differentiation, whereby inhibitors are repressed upon the
initiation of differentiation [11].
Transcriptional changes are mediated by changes to the
chromatin architecture, and a well-characterized modification
occurring at the very early stages of differentiation in OPCs is the
deacetylation of lysine residues on histone tails. This type of
modification is required for OPC differentiation during develop-
ment [16–19] and for efficient remyelination in disease [20].
Removal of acetyl groups from histone tails is carried out by a
family of enzymes called histone deacetylases (HDACs). Inhibition
of HDAC activity at the onset of oligodendrocyte differentiation
prevents the morphological changes and myelin gene expression
which are attributed to oligodendrocyte maturation [17].
Although it has been previously proposed that HDAC activity
targets the down-regulation of transcriptional inhibitors at the
onset of oligodendrocyte progenitor differentiation [19–21], the
identification of HDAC target genes remains elusive. We have
approached this issue by generating new tools to interrogate the
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18088oligodendrocyte transcriptome and comparing the kinetic profile
of gene expression in differentiating OPCs in physiological
conditions, with that of OPCs treated with the HDAC inhibitor
trichostatin A (TSA). Although several studies have been
previously published on the oligodendrocyte transcriptome during
development [22–25] or in demyelinating disorders [26–28], the
issue of temporal expression profiling and co-regulation of
functionally related genes has not been addressed. In this
manuscript we first describe a kinetic clustering algorithm to
define the sequential patterns of genes expressed during OPC
differentiation and then we define HDAC-target genes.
Results
Dynamic co-expression of genes involved in the same
biological processes
To understand the dynamics of global gene expression during
oligodendrocyte differentiation, we analyzed a comprehensive
microarray dataset which included expression values of all
transcripts during a detailed time course of oligodendrocyte
progenitor differentiation. This dataset was obtained from RNA
samples collected at D0 (Day 0), D1, D2, D3, D5, D7, and D9
from primary OPCs that were differentiated by removal of the
mitogen platelet derived growth factor (PDGF-AA) and the
addition of thyroid hormone (T3) [25]. The affymetrix standard
internal controls were used to normalize the signals in the
microarray chip. The average probe signal for an entire
microarray dataset was used to normalize the different samples.
Each signal was averaged among distinct biological replicates at
each time point. The analysis described here did not include any
normalization to a particular set of ‘‘housekeeping genes’’, but was
based on the raw values. Only 3,405 probe sets (representing 2,249
annotated genes) out of 26,202 were further analyzed because they
exhibited at least a two-fold expression level change during the
course of differentiation. These data were subjected to a consensus
clustering algorithm (K*=7, in this case) to define the temporal
profile of gene expression. This unbiased analysis of the
oligodendrocyte transcriptome, revealed 12 distinct significant
patterns of gene expression, each containing a certain number of
transcripts. For this reason they were called ‘‘clusters’’ (Fig. 1A.
For a full list of genes included in each cluster see Table S1).
Clustering was performed by taking into account the overall
temporal kinetics of gene expression throughout the differentiation
process and not by comparing normalized transcript levels at each
discrete time point. Genes whose expression decreased over time
in differentiation conditions, were found within clusters 1–6.
Transcripts in clusters 1–3 were rapidly down-regulated prior to
day 3 whereas genes within clusters 4–6 were transiently
upregulated and then returned to basal levels. In addition, genes
within cluster 1 were down-regulated within the first day of
differentiation, whereas genes in cluster 2 were down-regulated
slightly afterwards, but prior to those in cluster 3. Genes whose
expression increased over time in differentiation conditions were
found within clusters 7–12. Genes within clusters 7–9 were rapidly
up-regulated prior to day 3, while those within clusters 10–12 were
characterized by a progressive increase throughout differentiation.
In some cases, genes with a similar timing of expression were
differentially clustered based on the transcript levels. For instance
cluster 7 transcripts increased to a greater extent than those within
cluster 8. The graphic representation of these clusters (as shown in
figure 1) is an indication of the average kinetic expression
throughout the OPC differentiation process and does not
represent the sum of normalized discrete average transcript levels
at each time point of differentiation. So while the graphic
representation of the kinetics of genes expression incluster 6 and
9 might reveal an apparent overlap if the graph is analyzed at a
given time point (i.e. the transcripts are up-regulated from day 0 to
day 3), genes that belong to one clusters are uniquely represented
only within that group (i.e. cluster 6 genes return to basal levels
and are thereore not included in cluster 9, whose genes continue to
be up-regulated throughout differentiation), based on the overall
expression profile evaluated throughout the process of oligoden-
drocyte differentiation. To provide a simpler classification of our
kinetic profiles we merged clusters into four groups: ‘early down’,
‘transient up, late down’, ‘early up’, and ‘late up’ genes based on
the temporal profile of expression (Fig. 1B).
In order to understand the general functions of co-expressed
genes we analyzed their gene ontology using the Database for
Annotation, Visualization and Integrated Discovery (DAVID)
software package [29,30]. Each cluster of co-expressed genes was
independently analyzed for enriched ontology terms found in
‘Biological process’ or ‘Cellular Compartment’ libraries. Enriched
terms(pValueofenrichment,10
23)werecomparedforallclusters
(for all enriched ontology terms see Table S2). Strikingly, we found
related ontology terms which were strictly correlated with specific
co-expressed clusters. For example, terms associated with cell cycle
(‘cell cycle’, ‘mitosis’, ‘M phase’, and ‘spindle’) were highly enriched
within cluster 3 and were not associated with any other cluster.
The sequentialwaves of gene expression reflected the order of the
biological processes occurring during the differentiation of oligo-
dendrocyte progenitors (Fig. 2). Clusters of genes which were down-
regulated during the early stages of differentiation included those
involved in RNA processing, such as Bat1a, Eif1a, Eif3S9, Eif4EBP1,
Nol5a, Smn1 (all found within cluster1) and the heterogenous nuclear
ribonucleoproteins hnRNPA1, hnRNPA2B1, hnRNPA3, hnRPD,
hnRNPH1, hnRNPR,a n dhnRNPU (all found within cluster 2). They
also included genes related to the cell cycle (e.g. Ccna2, Cdc2a,
Cdc25b, Ccnb1, Gmnn, Top2a) and several important transcriptional
regulators (e.g. Arx, Cebpb, Egr1, Id2, Klf4, Klf10 and Sox11). These
findings are consistent with the concept that the early stages of
OPCs differentiation are characterized by events modulating RNA
processing [5,31–33], cell cycle control [34–36], and down-
regulation of transcriptional inhibitors of differentiation [13,14].
The genes associated with cytoskeletal remodeling (e.g. Ptk9,
Sema6a, Sirt2) were enriched within the first wave of increased
genes (‘Early Up’), whereas genes involved in protein and vesicular
transport (e.g. Abca1, Rab5a, Rab21, Vamp1) were enriched within
the second wave of increased gene clusters (‘Late Up’) and this
kinetic pattern underscores the functional relevance of cytoskeletal
components for RNA and protein transport, myelin formation and
stability [37]. Interestingly, we observed that several genes
involved in lipid metabolism (e.g. Elovl6, Fdft1, Fdps, Hmgcr, Lss,
Scd1) were initially up-regulated but returned to basal levels at the
end of the differentiation process (cluster 4 of figure 1), while
others continued to be expressed at high levels (e.g. Acsl1, Dgat2,
Pnlip, Sc5d). Some myelin-specific transcripts (e.g. Mbp, Plp, Ugt8)
and peroxisome-specific genes (e.g. Abcd3, Cat, Pxmp4, Scp2) were
identified in ‘early up-regulated’ clusters and followed similar
kinetics to the enzymes involved in lipid metabolism. The group of
genes displaying a late increase during oligodendrocyte differen-
tiation included myelin transcripts such as Mag, Mobp, and Mog.
Thus, the kinetic analysis of the transcriptome revealed a
temporal sequence of events in which global down-regulation
occurred during the very early steps of OPC differentiation (1,429
out of 1,766 total down-regulated probesets prior to day 3). This
wave was followed by a later increase of gene transcripts related to
lipid metabolism and myelin proteins (1,057 probesets out of 1,639
probesets that were up-regulated after day 3). OPC differentiation
HDAC Regulated Genes
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occurred around cell cycle exit and preceded the synthesis of lipid
enzymes and myelin genes.
Inhibition of HDAC activity halts the transcriptional
program of differentiation
Previous work had suggested that gene repression at the onset of
oligodendrocyte differentiation is associated with HDAC activity
and is necessary for myelination [16,17,20]. In an effort to define
target genes of HDAC activity during oligodendrocyte differen-
tiation we performed microarray analysis on OPCs differentiated
for one day in the presence or absence of the HDAC inhibitor
Trichostatin A (TSA). A total of 2,592 genes (3,958 probesets)
exhibited at least a two-fold difference compared to controls upon
TSA treatment, and of these genes 66% were increased (1,718
genes) and 33% were decreased (874 genes) in expression.
We then asked whether the effect of HDAC inhibition was
random across the genome (independent of the transcriptome), or
rather selective for a subset of genes which are regulated during
oligodendrocyte differentiation. Since the TSA treatment was limited
to the first 24 hours, we analyzed genes within the early
oligodendrocyte transcriptome (clusters 1–9, totaling 1,991 genes)
for their responsiveness to TSA treatment. We found that the ‘TSA
sensitive’ genes (total of 2,592 genes) included 526 genes that were
significantly increased or decreased during the early stage of OPC
differentiation. A Chi Square test with Yates correction revealed that
this overlap of TSA affected genes (total n=2592), and the set of
genes normally changed during the early time course of oligoden-
drocyte differentiation (n=1991) was not independent of one another
(X
2=98.1,p,0.0001).Wetherefore conclude that HDAC inhibition
on oligodendrocyte differentiation was not the consequence of a
global change in gene expression, but rather due to a specific effect on
genes modulating the oligodendrocyte differentiation program.
Therefore we further invested the role of HDAC target genes so
we could learn more about oligodendrocyte biology.
HDAC inhibition increases the expression of
transcriptional regulators, but not cell cycle genes
We first asked whether TSA treatment similarly affected all the
distinct gene clusters or whether the effect was prevalent in specific
Figure 1. Clustering of co-expressed genes during oligodendrocyte differentiation. A. Microarray probes whose levels changed by $2 fold
during oligodendrocyte differentiation were grouped into co-expressed clusters depending on their expression kinetics during the entire time course
of differentiation. Note that the raw values were analyzed over time and they were not normalized against reference genes. Each gene cluster is
represented by a graph displaying the average expression level (y-axis) over the entire course of oligodendrocyte differentiation (x-axis). Cluster ID
numbers are in the upper corner of each graph and the number of probes within each cluster is found in the lower right of each graph. B. Clusters
were further grouped together to define ‘early down’, ‘transient up, late down’, ‘early up’ and ‘late up’ groups. The total number of probesets and
genes is listed on the right.
doi:10.1371/journal.pone.0018088.g001
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PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e18088Figure 2. Co-expressed genes have similar biological functions. Each cluster of co-expressed genes was analyzed for ontology, as listed on
the top of the chart. Non-redundant ontology terms were listed and are sub-categorized according to function. Terms with a statistically significant
enrichment (p Value,10
23) above the background set (whole genome) are represented as a green box for each cluster.
doi:10.1371/journal.pone.0018088.g002
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expression of genes within cluster 1 (immediately down regulated
genes) and comprised several transcriptional regulators (e.g. Cebpb,
Cited2, Egr1, Egr1, Klf4, Klf10, Lmo4, Nab2, Nolc1, Sox11, and
Zcchc12), including those that have been reported to be expressed
in immature OPCs (i.e. Egr1 and Sox11) [38,39]. Overwhelmingly,
genes within the other clusters were down-regulated in response to
TSA and included transcripts involved in lipid metabolism, myelin
transcripts and other genes previously reported to be critical for
oligodendrocyte development such as Qki and the transcription
factors Nkx2.2 and Nkx6.2 (Fig. 3), for a partial list of genes changed
upon TSA treatment see Table 1.
The microarray data were validated by reverse transcription
followed by quantitative PCR (qRT-PCR) with primers specific for
transcription factors increased within cluster 1 such as Cited2, Egr1
and Sox11 (Fig. 4A). We further validated the decreased expression
of the myelin specific genes Mbp, Plp, Mag, and Mog in response to
TSA treatment by qRT-PCR (Fig. 4A). It is worth noting that the
transcript levels of genes involved in RNA processing and cell cycle
regulation (i.e. Asf1b, Cycin B, Cyclin E, Cyclin F, Cyclin H, Cdc27,
Cdc2A, CdcA1, Topo1, and Mki67) were much lower in the TSA-
treated samples than in controls, we further validated also the
decreased expression of Asf1b, Ccnb1, and Ccne1 (Fig. 4A). The
dramatic decrease of the transcripts for cyclins and other positive
regulators of proliferation was consistent with the idea that
inhibition of HDAC activity impaired differentiation indepen-
dently from proliferation, since the cells remained capable to exit
from the cell cycle [17]. Based on this overall analysis of the
oligodendrocyte transcriptome after TSA treatment, we conclude
that TSA-sensitive genes are involved in a global halt of the
transcriptional network of oligodendrocyte differentiation, occur-
ring after cells have exited from the cell cyle.
We next determined whether TSA treatment of OPCs was
associated with increased histone acetylation at the promoters of
genes displaying increased transcript levels. We chose to focus on
the analysis of the Sox11 promoter and investigate the acetylation
of lysine residues on the tail of histone H3 at position 9 (AcK9H3),
because this is a critical residue that has been linked to the
activation of transcription of Egr1 [40–42]. By performing
quantitative chromatin immunoprecipitation (qChIP) we found
that histone H3 at the transcriptional start site of Sox11 was
hyperacetylated on lysine 9 residue in TSA treated cells, compared
to untreated controls (Fig. 4B). In contrast, acetylation of lysine 9
at the transcriptional start sites of the myelin genes Mag and Mog
remained constant, despite their decreased transcript levels after
TSA treatment. Interestingly, the acetylation of lysine 18 of
Histone H3 was increased by TSA in all gene promoters analyzed
and did not correlate with increased gene expression. Together
these data suggest a residue-specific role of acetylation, with K9
specifically involved in the regulation of transcription. Together
with previous studies on Egr1 [40–42], our results on the Sox11
promoter indicate that acetylation is an important mechanism of
modulation of genes involved in transcriptional repression, but not
of myelin genes.
Egr1 and Sox11 expression inhibit oligodendrocyte
differentiation
Because several genes expressed in cluster 1 encoded for
transcriptional inhibitors of oligodendrocyte differentiation we
asked whether Egr1 or Sox11, that were part of cluster 1 had a
similar inhibitory role. We first confirmed that Egr1 and Sox11
were expressed in OPC, and down-regulated during differentia-
tion (Fig. 5A). Next, we tested the consequences of retaining their
expression, using over-expression followed by the induction of
differentiation for 4 days (Fig. 5B). The over-expression of either
Egr1 or Sox11 in primary OPCs did not affect the expression of
astrocytic or neuronal markers on OPCs, but decreased the
proportion of oligodendrocytes immunoreactive for antibodies
Figure 3. HDAC inhibition in differentiating OPCs halts the transcriptional program of differentiation. OPCs were differentiated for one
day in the absence or presence of the HDAC inhibitor Trichostatin A (TSA), mRNA was extracted and analyzed by microarray analysis. TSA sensitive
genes were overlapped onto the early oligodendrocyte transcriptome (clusters 1–9). A. The light yellow bar graphs represent the number of genes
within each kinetically defined cluster which were increased by TSA treatment. B. The light blue bar graphs represent the number of genes which
were decreased by TSA treatment. Groups of genes enriched in a particular ontology group are indicated and labeled.
doi:10.1371/journal.pone.0018088.g003
HDAC Regulated Genes
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Sox11 over-expression modulated the levels of several other
transcripts that characterize the progression to mature oligoden-
drocytes (Fig. 6). Egr1 overexpressing cultures, for instance were
characterized by levels of Olig1, Mrf, and Ugt8 significantly lower
than GFP transfected controls. Similarly, Sox11 overexpressing
cultures were characterized by lower transcript levels for Mrf and
Ugt8 compared to controls. Mrf is a critical transcription factor
necessary for the differentiation of oligodendrocytes [43], but still
very little is known about its upstream regulation. Our data
identify Egr1 and Sox11 as potential upstream regulators of Mrf
expression. Together, these data demonstrate a functional role of
HDAC-regulated cluster 1 genes in modulating oligodendrocyte
differentiation.
Discussion
Differentiation of OPCs into myelinating OLs encompasses a
complex sequence of events including cell cycle exit, RNA
processing, branching, synthesis of myelin proteins and lipids
and membrane wrapping around the axon [36,44]. At a molecular
level, these events are modulated by regulating the levels of
transcripts through the interplay between chromatin regulators,
transcription factors and microRNAs. While studies on the
oligodendrocyte transcriptome have revealed the identity of many
genes contributing to these processes [22–25,33,45,46], it remains
unclear whether the process is stochastic or regulated by intrinsic
mechanisms of kinetic regulation of gene expression that are
dependent on the activity of chromatin modulators. In an effort to
understand the rules regulating global gene expression during
oligodendrocyte progenitor differentiation, we designed a kinetic
clustering algorithm to interrogate the oligodendrocyte transcrip-
tome [25] and characterized clusters of co-regulated genes
defining complex waves of gene expression. We classified genes
on the basis of two criteria: temporal regulation and fold change,
and limited our analysis to transcripts whose levels changed at least
two-fold during the time course of differentiation. These
parameters set a stringent threshold and defined 12 clusters of
co-expressed genes. We then used ontology software to define the
biological functions associated with these clusters. We found that
genes involved in RNA splicing and processing, transcriptional
regulation and cell cycle control were rapidly down-regulated,
while those involved in lipid metabolism, cytoskeletal reorganiza-
tion and myelin gene products were subsequently up-regulated
and followed by a later wave of transcripts affecting vesicular
transport, late myelin genes and survival. This analysis provides
the first evidence of a temporally co-regulated wave of gene
expression that is consistent with the subsequent modulation of cell
cycle exit and RNA regulation followed by increased cytoskeletal
and myelin-specific proteins, and finally lipid transport [47].
Overall we find that during the time course of OPC differenti-
ation, genes with parallel kinetics of expression are further related
to one another and contribute to similar biological functions.
The prominent down-regulation of genes at the early stages of
the differentiation process was in agreement with previous studies
showing that the levels of transcriptional repressors, such as Id2
and Id4 [48–50], Hes5 [51,52] and Tcf7l2 [19,21,53] need to be
down-regulated in order to allow myelin gene expression to
proceed. Previous studies, including our own, had previously
shown that transcriptional repression mediated by HDAC activity
is necessary for oligodendrocyte differentiation, particularly during
the initial stages [16–19], however the network of transcripts that
is changed by HDAC activity has remained elusive. By comparing
the results of gene-expression profiling in OPCs treated with the
HDAC inhibitor TSA with the oligodendrocyte transcriptome, we
identified transcription factors that act as inhibitors of oligoden-
drocyte differentiation. The majority of the HDAC-regulated
genes included transcriptional regulators within the first cluster of
rapidly down-regulated genes, but not cell cycle genes. Among
cluster 1 gene targets for HDAC, we detected Egr1 and Sox11 as
Table 1. Representative genes whose expression is
significantly altered by TSA treatment.
Gene
Symbol
Cluster
Number Gene Function
Fold change in
expression
BEX4 1 Transcriptional Regulator 2.8
CEBPB 1 Transcriptional Regulator 3.0
CITED2 1 Transcriptional Regulator 2.3
EGR1 1 Transcriptional Regulator 4.9
EGR2 1 Transcriptional Regulator 6.7
FHL3 1 Transcriptional Regulator 2.5
KLF10 1 Transcriptional Regulator 2.5
KLF4 1 Transcriptional Regulator 3.9
LMO4 1 Transcriptional Regulator 2.4
NAB2 1 Transcriptional Regulator 4.3
NOLC 1 Transcriptional Regulator 17.8
RGD1562672 1 Transcriptional Regulator 3.7
SOX11 1 Transcriptional Regulator 2.9
ZCCHC12 1 Transcriptional Regulator 6.1
HNRPA1 2 RNA processing 22.5
HNRPA2B1 2 RNA processing 22.5
HNRPH1 2 RNA processing 22.7
MCM4 2 DNA Replication 22.7
MCM6 2 DNA Replication 22.6
MCM7 2 DNA Replication 22.4
ASF1B 3 Cell cycle/cyotskeleton 22.8
BARD1 3 Cell cycle/cyotskeleton 25.6
CDC2A 3 Cell cycle/cyotskeleton 24.3
FOXM1 3 Cell cycle/cyotskeleton 24.6
CCNB1 5 Cell cycle/cyotskeleton 25.9
CCNB2 5 Cell cycle/cyotskeleton 25.9
ACSL1 7 Lipid Metabolism 22.1
DHCR24 7 Lipid Metabolism 23.9
PCYT2 7 Lipid Metabolism 22.7
PNLIP 7 Lipid Metabolism 223.4
CD9 7 Myelination 22.3
CNP1 7 Myelination 22.8
MBP 7 Myelination 22.8
PLP 7 Myelination 23.5
MAG 10 Myelination 220.7
MOBP 10 Myelination 22.8
MOG 10 Myelination 22.1
Gene symbols are listed along with their kinetic cluster number describing their
normal expression during oligodendrocyte differentiation (see figure 1), the
functional gene ontology groups which they are associated (see figure 2), and
the expression fold change found by microarray analysis in OPCs differentiated
for one day in the presence of TSA compared to those OPCs differentiated for
one day without TSA.
doi:10.1371/journal.pone.0018088.t001
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at high levels they suppressed the attainment of a mature
phenotype. We also showed that HDAC inhibitors enhance
acetylation of critical lysine residues of histone H3 at the promoter
region of Egr1 and Sox11 and this correlates with the increased
levels of these transcripts [54]. Interestingly, TSA did not
significantly modulate acetylation of histones at myelin gene
promoters, thereby suggesting that acetylation/deacetylation is a
signal that selectively modulates the first wave of down-regulated
genes, but is not involved in the modulation of later genes.
Additional genes up-regulated by TSA-treatment included
several transcripts associated with alternative lineage choices, such
as NeurodD1, Pou4f1, Numb, Bace2, Hes1 and Dlx5 for the neuronal
lineage and Bmp6 and S100 for the astrocytic lineage. The
enrichment of these genes suggests that histone deacetylation in
OPCs contributes to the suppression of genes affecting alternative
cell fates. The remaining gene transcripts that were increased by
TSA treatment but were outside of our stringent definition of the
oligodendrocyte transcriptome included genes mediating immune
response (DAVID p value=5*10
223), such as Cathepsin S, Rab3d,
and Toll-like receptor 2. Interestingly, of the several hundreds of genes
that were immediately down regulated upon oligodendrocyte
differentiation, only one quarter were regulated by HDAC
inhibition. This suggests that additional mechanisms, possibly
including histone methylation and microRNA-mediated repression,
are responsible for the observed decrease in transcript levels. Indeed
microRNAs have recently been shown to regulate the mRNA levels
of many genes which are down regulated early during oligoden-
drocyte differentiation, such as PDGFRalpha, Sox6 and Hes5 [55,56].
Cumulatively, these data promote a model in which various
OPC-expressed transcription regulators repress oligodendrocyte
differentiation and maintain OPCs in an immature state. Upon
initiation of differentiation, HDACs directly deacetylate lysine
residues of histones occupying the promoters of these OPC-
expressed repressive transcription factors. The necessary decrease
in the levels of transcriptional inhibitors occurs as the OPCs
Figure 4. HDAC activity directly regulates the expression of Sox11. A. Quantitative RT-PCR was performed to validate changes of transcript
levels for transcriptional regulators, cell cycle regulators and myelin specific genes in OPCs either untreated or treated with TSA for one day. The data
reflect the results of qPCR results performed in duplicate from 2–4 independent biological replicates (* p,0.05; ** p,0.01, *** p,0.001 as
determined by two-tailed t-test). B. Quantitative Chromatin Immunoprecipitation of samples collected from OPCs either untreated or treated with
TSA and then immunoprecipitated with antibodies specific for HDAC1, HDAC2, acetylated lysine 9 on histone H3, and acetylated lysine 18 on histone
H3. A mock immunoprecipiation was used (not shown) as a negative control. The experiment was oerformed in triplicate from two separate
biological replicates. Data are represented as mean 6 SEM, * p,0.05 as determined by two-tailed t-test.
doi:10.1371/journal.pone.0018088.g004
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PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e18088Figure 5. Down regulation of Sox11 and Egr1 is important for normal oligodendrocyte progenitor differentiation. A. Quantitative RT-
PCR to measure Sox11 and Egr1 transcript levels in RNA samples isolated from OPCs differentiated for 0, 24, 48, 72, and 96 hours. Error bars 6S.E.M,
** p,0.001, * p,0.005 as determined by student two-tailed T-test. B. Images of purified P7 rat OPCs transfected with either pC1-eGFP alone (A-B,
‘‘control’’), or co-transfected with either pSp-Egr1 (C–D) or pSp-Sox11 (E–F) expression vector. Transfected OPCs were cultured for 3 days in mitogen-
free (-PDGF) medium to induce differentiation, and subsequently immunostained for GFP (white; A2-F2) plus either CNP (red; A1, C1, E1) or MBP (red;
HDAC Regulated Genes
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deacetylases and microRNAs [55,56].
More generally, our analysis of the oligodendrocyte transcrip-
tome has led to a detailed description of the kinetics and the
biological effects of changes in transcript expression during the
process of oligodendrocyte differentiation. By using this annotated
transcriptome as a resource we are able to understand the gene
expression expression changes we see as a result HDAC inhibition.
We envision that this approach will useful for understanding the
requirement of other transcriptional events during OPC differen-
tiation, and we hope that that our annotated transcriptome will
provide a resource for future studies.
Materials and Methods
Clustering Analysis
The expression data for the timecourse of oligodendrocyte
differentiation used for the clustering analysis was previously
Figure 6. Over expression of Egr1 or Sox11 inhibits the expression of differentiation activators. Quantitative RT-PCR of RNA samples
collected from OPCs cultured as decribed in figure 5 and amplified with primers specific for Egr1 and Sox11 to validate over-expression. The transcript
levels of oligodendrocyte lineage markers (PDGFRalpha, Olig1), transcriptional activators of OPC differentiation (Mrf, Sox10), myelin genes (Ugt8, Mbp,
Mag), and of an astrocytic gene (Gfap) were measured in Egr1 or Sox11 over-expressing cells and compared to GFP over-expressors. Data are
represented as mean 6 SEM, from 3 independent experiments (*p,0.05 as determined by two-tailed t-test).
doi:10.1371/journal.pone.0018088.g006
B1, D1, F1) and counterstained with DAPI (blue; A1-F1) to visualize nuclei. Yellow arrows indicate GFP
+ transfected cells co-expressing CNP or MBP;
green arrows indicate GFP
+ cells negative for CNP or MBP expression; red arrows indicate untranfected cells expressing CNP or MBP. Scale bar =
200 mm. C. Percentages of control (GFP-only), pSp-Egr1, and pSp-Sox11 transfected cells expressing the indicated oligodendrocyte specific markers
(CNP, MBP, or MOG). Error bars 6S.E.M., n=6–16 samples from 2–5 independent experiments, ** p,0.001, * p,0.005 post-hoc SNK test vs. control.
doi:10.1371/journal.pone.0018088.g005
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used for the clutering analysis without further normalization.
In order to extract significant patterns of expression from high
dimensional transcriptional profiling data, we utilized our previous
work on consensus clustering to obtain clusters of co-expressed
genes [57]. The approach starts by constructing the agreement
matrix (AM). To produce the AM, a number of different clustering
methods along with different metrics (Euclidean, Manhattan, and
Pearson correlation [58]) were used to minimize the biases
associated with individual clustering methods and/or distance
metrics [59]. In our implementation, we are using hierarchical
clustering (hclust), divisive analysis clustering (diana), fuzzy analysis
clustering (fanny), partitioning around medoid (pam) with Pearson
correlation and Manhattan metric, k-means (kmeans), fuzzy c-
means (cmeans), self-organizing map (som), and model-based
clustering (mclust) with Euclidean metric as the core clustering
methods [60,61]. Since clustering results are highly dependent on
the initial number of clusters, the sensitivity of the AM was also
examined as a function of the input number of clusters to find a
‘suggestive’ optimal number of clusters K* for the dataset [57].
Subsequently, an agglomerative hierarchical clustering algorithm
is applied to cluster the data using the AM as the input similarity
distance matrix (consensus clustering). The algorithm starts with
every gene belonging to a cluster and then grouping two clusters
into a new one at each iteration. Any two genes belonging to the
new cluster need to have an agreement level greater than or equal
to a user-defined agreement level d (70% in this study). Finally, we
applied a trivial-cluster removal procedure with a given p-value
(0.05 as default) and obtained twelve significant patterns of
expression which are shown to be critical in the dynamic
transcriptional program of differentiating oligodendrocytes. De-
tailed discussion on the algorithm and its implementation can be
found in our earlier publication [57].
Ontology Analysis
Ontology analysis of each co-expressed group of genes was
performed using the DAVID ontology software as previously
described [29,30] using the whole genome as the background
dataset and an EASE score , 10
23 considered highly enriched
ontology groups.
Animals
Sprague-Dawley rats were purchased from Taconic. All the
procedures described in this manuscript were performed to
minimize distress and use of animals, in accordance to the
protocol with approval number 08–676, that was reviewed and
approved by the Institutional Animal Care and Use Committee
(IACUC) at Mount Sinai School of Medicine.
Cell Culture
For most experiments, OPCs were isolated from the cortex of
postnatal day 1 rats, and cultured according to McCarthy and de
Vellis [62]. After being shaken from the flasks, OPCs were labeled
with the A2B5 antibody and further purified using magnetic beads
(Miltenyi Biotec, Auburn, CA). Cells were maintained proliferat-
ing by the addition of PDGF (10 ng/ml) in ODM medium
(DMEM, 100 mg/ml albumin, 100 mg/ml apo-transferrin, 16 mg/
ml putrescine, 0.06 ng/ml progesterone, 40 ng/ml selenium,
5 mg/ml insulin, 1 mM sodium pyruvate, 2 mM L-glutamine,
100 units/ml penicillin, 100 mg/ml streptomycin). The removal of
mitogens from the medium (mitogen withdrawal) was considered
as the start of differentiation. This procedure led to a 95% pure
population of A2B5+ cells. Once the cells were differentiated in
chemically define medium, 90–95% of the cells expressed myelin
and GalC by 5 days of differentiation. Treatment with trichostatin
A (TSA, 30 nmol), was initiated when the culture medium was
replaced with mitogen-free chemically defined ODM medium.
The microarray data form Dugas et al. where obtained from
cultures containing .95% OL-lineage cells. Upon differentiation,
these cultures contained 90–95% GalC
+/MBP
+ OLs. Less than
1% of the cells in the culture expressed the neuronal marker
Neurofilament-H and the remaining 5% were astrocytes.
Microarray
For TSA treatedand nontreated samples microarray analysis was
processed in the Microarray Shared Research Facility at MSSM.
Briefly, 50 ng of total RNA was reverse transcribed using T7-
poly(dT) primer and converted into double-stranded cDNA. The
cDNA was used as a template for subsequent in vitro transcription
with biotin-labeled UTP at 37oC for 16 h using Genechip 3
1 IVT
express kit (Affymetrix). The resulting biotin-labeled cRNA was
chemically fragmented, made into hybridization cocktail and
hybridized to the Mouse Genome 430 Plus 2.0 arrays (Affymetrix)
according to the Affymetrix GeneChip protocol. The array images
were generated through a high-resolution GeneChip Scanner 3000
7G (Affymetrix), then converted to digitized data based on MAS 5.0
within the GeneChip Operating Software (GCOS). The data were
normalized by scaling so that all chips had an average signal
intensity of 150.
Data were deposited into ArrayExpress with accession no.
MEXP-3028. All the data is MIAME compliant, as detailed on the
MGED Society website http://www.mged.org/Workgroups/
MIAME/miame.html.
Cell transfection and immunostaining
For transfection experiments, OPCs were purified from P7
Sprague-Dawley rat brains as described previously [25] and
purified by a negative selection on Ran-2 and GalC-coated
immunopanning plates followed by a positive selection on O4-
antibody coated immunopanning plates. All the procedures were
in accordance to the IACUC Institutional committee (protocol 08-
676). OPCs were plated into poly-D-lysine (pDL) coated tissue
culture plastic flasks cultured in previously-described DMEM-Sato
based, serum-free medium which contained 10 ng/ml PDGF-AA
+ 1 ng/ml NTF3 [25] for 6–7 days in vitro (DIV). OPCs were
then enzymatically lifted and transfected as described previously
[25], using Lonza/Amaxa (Gaithersburg, MD) OPC nucleofector
kit; 2–3610
6 rat OPCs per transfection. Transfections were
performed with 3.5 ug pC1-eGFP (control) or 1.5 ug pC1-eGFP +
2.5 ug pSp-Egr1/pSp-Sox11. Following transfection, OPCs were
cultured on poly-D-lysine (pDL) coated glass coverslips in DMEM-
Sato based medium lacking PDGF and NTF3 for 3 (CNP and
MBP stained) or 4 (MOG staining) DIV. All cultures were
maintained at 37uC in 10% CO2. Immunostaining of OPC and
oligodendrocyte cultures for 29,39-cyclic nucleotide 39 phosphodi-
esterase (CNP), Myelin basic protein (MBP), Myelin oligodendro-
cyte glycoprotein (MOG), and Green fluorescent protein (GFP)
expression was performed as described previously [25]. GFAP
(1:1000) and TuJ1 (1:500) were used to detect astrocytic and
neuronal markers respectively.
Plasmids
pC1-eGFP (Clontech, Mountain View, CA, 6084-1) was used to
mark transfected cells with CMV-promoter driven eGFP production.
pSPORT6-Egr1 was ordered from OpenBiosystems (Huntsville, AL)
(EMM1002-4), in which a full-length EST clone of the human Egr1
cDNA is driven by a CMV promoter (EST clone was sequence-
verified to contain the full-length Egr1 coding sequence). pSPORT6-
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MMM1013-9335073) cloned into the EcoR1 (59)a n dN o t I( 3 9)s i t e s
in the pSPORT6 vector (Egr1 excised, Sox11 inserted).
Quantitative RT-PCR
RNA samples were isolated using TrizolH Reagent following
manufacturer’s instructions and cleaned using the RNeasy Mini kit
(Qiagen, Hilden, Germany). The concentration of RNA was
quantified using a nanodrop spectrophotometer. 0.5 mg of total
RNA was used for a 20 ul reverse transcription (RT) reaction,
using the SuperScript RT-PCR kit (Invitrogen). Quantitative RT-
PCR was performed using Stratagene SYBR Green PCR master
mix in an Applied Biosystems real-time PCR machine with
primers to detect select mRNA targets. The melting curve of each
sample was measured to ensure the specificity of the products and
samples with an unexpected melting curve were excluded from
further analysis. Data were normalized to the internal control
Gapdh and analyzed using Pfaffl DDCt method [63].
Primers detecting RAT gene products used for TSA
studies
See Table 2.
Primers detecting MOUSE gene products used for
overexpression studies
See Table 3.
Quantitative Chromatin Immunoprecipitation Assay
(qChIP)
Protocol was adapted from the Q
2ChIP assay as described [64].
Rat OPCs (4610
6) were crosslinked in 1% formaldehyde, lysed in nuclear lysis buffer (50 mM Tris-HCL (ph 8.0), 10 mM EDTA,
1% SDS, Protease Inhibitors (Roche) and PMSF) and sonicated
using a Bioruptor (Diagenode) sonicator to produce chromatin
with an average length of 250–500 base pairs. Chromatin was
aliquoted and immunoprecipitated using protein A magnetic
beads (Dynabeads- Invitrogen 100.01D) coated with 2 ug of
antibody. Histone H3-AcK9 – abcam Ab1191, HDAC1 antibody
– Upstate PA1-860, HDAC2 – abcam ab7029. A mock
immunoprecipitation was set-up as control (No antibody).
Immunoprecipitations were carried out overnight. Following
immunoprecipitation, beads were washed 4 times with wash
buffer (10 mM Tris-HCl(ph 7.5), 1 mM EDTA, 1 mM EGTA,
1% Triton X-100, 0.1% SDS, 0.1% Na-deoxycholate, 140 mM
NaCl) and 2 times with TE buffer (10 mM Tris-HCl (ph 8.0),
10 mM EDTA). Immunoprecipitated chromatin and input DNA
were reverse crosslinked in elution buffer (20 mM Tris-HCl
(ph 7.5), 5 mM EDTA, 50 mM NaCl, 1% SDS) with the addition
of proteinase K (50 ug/ml) by heating (68uC) and shaking
(1300RPM) using a thermomixer (Eppendorf) for four hours.
DNA was purified from the elution using phenol-chloroform
followed by an overnight ethanol precipitation at 220uC. DNA
was eluted in 200 ul of TE buffer.
Quantitative PCR was performed using primers to detect
specific sites of rat gene promoters. Sox11 F-59 TCT TGG ACC
ACA CCA TGA AG, R- 59 GAA GCC GAG AGC AAC CTG,
Mag F-59 CTC CTC CCC TTC CTC CAT TAA and R-
59GACAACAGGTTCCACCTTTCAAC Mog F-59 AAT ATC
TGG CAA GGG TGA CG, R-59 CAG GAT CAG GCC AAG
CTA AG. Sonicated chromatin from an unrelated sample was
used to determine primer efficiency and as a reference for amount
of DNA in each sample. The amount of immunoprecipitated
DNA was quantified relative to the amount of the input DNA for
each sample.
Table 2. Primers detecting RAT gene products used for TSA
studies.
mRNA target name Forward primer Reverse primer
Asf1b GGA CGC CGT GGG
TGT GAC TG
CCG AAG CTC CGG
GTC TGG GT
Ccnb1 TGT GGA GCA GCA
TAC TTT GG
CTC CGT GTG GGA
CAG GTA GT
Ccne1 ATG TCC AAG TGG
CCT ACG TC
TCT GCA TCA ACT
CCA ACG AG
Cited2 TCT TGG CTG CAT
GAA CTT TG
CAC TGA CGA CAT
TCC ACA CC
Egr1 TGC ACC CAC CTT
TCC TAC TC
AGG TCT CCC TGT
TGT TGT GG
Gapdh AGA CAG CCG CAT
CTT CTT GT
CTT GCC GTG GGT
AGA GTC AT
Id2 ACA AGA AGG TGA
CCA AGA TGG AA
GCG ATC TGC AGG
TCC AAG AT
Mag GCT GGG AGG GAA
ATA CTA TTT CC
GAC GCT GTG CTC
TGA GAA GGT
Mbp CTC CCA GCT TAA
AGA TTT TGG AAA
AAA TCG GCT CAC
AAG GGA TTC
Mog GAG GGA CAG AAG
AAC CCA CA
CAG TTC TCG ACC
CTT GCT TC
Plp GCA AGG ATC TTT
CAC CCT TAG AAA
TGG CTG AGT TAG
GGC TTA AAT AGT C
Sox11 TCA TGT TCG ACC
TGA GCT TG
TAG TCG GGG AAC
TCG AAG TG
doi:10.1371/journal.pone.0018088.t002
Table 3. Primers detecting MOUSE gene products used for
overexpression studies.
mRNA target name Forward primer Reverse primer
Egr1 GCCTCGTGAGCA
TGACCAAT
GCAGAGGAAGACG
ATGAAGCA
Gapdh ACCCAGAAGACT
GTGGATGG
CACATTGGGGGTAG
GAACAC
Gfap GCCACCAGTAA
CATGCAAGA
CGGCGATAGTCGTTA
GCTTC
Mag GGTGTTGAGGGA
GGCAGTTG
CGTTCTCTGCTAGGC
AAGCA
Mbp AAATCGGCTCAC
AAGGGATTC
CTCCCAGCTTAAAGAT
TTTGGAAA
Mrf TGGCAACTTCAC
CTACCACA
GTGGAACCTCTGCAAA
AAGC
Olig1 CGACGCCAAAGA
GGAACAG
GCCAAGTTCAGGTCCT
GCAT
Pdgra TTGGTGCTGTTGG
TGATTGT
TCCCATCTGGAGTCGT
AAGG
Sox10 GGAGATCAGCCA
CGAGGTAATG
GTTGGGTGGCAGGTAT
TGGT
Sox11 TCCAGGTCCTTAT
CCACCAG
GACGACCTCATGTTCG
ACCT
Ugt8 TGGTTGACATACT
GGATCACTATACT
CGATCACAAATCCACA
CATATCATT
doi:10.1371/journal.pone.0018088.t003
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Table S1 Full list of probes and gene symbols assigned
to each cluster. Included in the table are the probe numbers
and genes names of those transcripts included in our clustering
analysis. For each gene we provide the overall characterizartion of
the kinetic profile (‘Early Down’, ‘Transient Up-Late Down’,
‘Early Up’ and ‘Late Up’), the cluster number (1–12) and the raw
values from the microarray dataset from Dugas et al, 2006.
(XLS)
Table S2 Full ontology search data separated by cluster
number. Complete summary table of all ontology terms
classifying clusters 1–12 and with a p Value,10
22. Within each
row, we list the ‘‘Go term’’, the number and the p Value for each
cluster (1–12) of co-expressed genes during oligodendrocyte
differentiation.
(XLS)
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